Nuvectis Pharma Inc (NVCT) financials · $304.5M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Nuvectis Pharma Inc (NVCT) $304.5M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$27.6M | -$19.8M |
| Net Income | -$26.4M | -$19.0M |
| EPS (Diluted) | -$1.32 | -$1.11 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $31.7M | $18.6M |
| Current Assets | $31.7M | $18.6M |
| Cash & Equivalents | $31.6M | $18.5M |
| Total Liabilities | $13.3M | $8.89M |
| Current Liabilities | $13.3M | $8.89M |
| Shareholders' Equity | $18.4M | $9.71M |
| Retained Earnings | -$99.7M | -$73.2M |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$16.0M | -$12.2M |
| Investing Cash Flow | N/A | N/A |
| Financing Cash Flow | $29.1M | $11.7M |
FAQ
What is NVCT P/E and revenue?
Nuvectis Pharma Inc (NVCT) $304.5M cap.
What is NVCT revenue?
NVCT income-statement cache has no revenue figure yet.
Is NVCT profitable?
Nuvectis Pharma Inc last cached net income is -$26.4M (FY2025).
What are NVCT total assets?
Nuvectis Pharma Inc last cached total assets are $31.7M (FY2025).
What is NVCT free cash flow?
No cached cash-flow row for NVCT yet.
Not investment advice. Cached statements, not a live tape.